| |
Unadjusted
|
Adjusted*
|
|---|
|
Outcome: long anticipated patient interval for rectal bleeding (> 1 week)
|
Outcome: long anticipated patient interval for rectal bleeding (> 1 week)
|
|---|
|
Proportion with long interval (%)
|
OR
|
95% CI
|
P-value
|
OR
|
95% CI
|
P-value
|
|---|
|
Recognition of unexplained bleeding as cancer symptom
|
|
Yes
|
13.3
|
Ref.
| | |
Ref.
| | |
|
No
|
19.7
|
1.59
|
1.41–1.79
|
< 0.001
|
1.90
|
1.58–2.30
|
< 0.001
|
|
Number of negative beliefs about cancer
|
|
0
|
13.0
|
Ref.
| | |
Ref.
| | |
|
1
|
13.8
|
1.07
|
0.98–1.18
|
0.147
|
1.11
|
1.00–1.22
|
0.051
|
|
2
|
14.4
|
1.13
|
1.01–1.27
|
0.034
|
1.21
|
1.07–1.37
|
0.002
|
|
3
|
15.8
|
1.26
|
1.06–1.48
|
0.007
|
1.41
|
1.18–1.69
|
< 0.001
|
|
≥ 4
|
20.3
|
1.71
|
1.34–2.18
|
< 0.001
|
1.97
|
1.51–2.57
|
< 0.001
|
|
Age group
|
|
50–59 years
|
16.6
|
Ref.
| | |
Ref.
| | |
|
60–69 years
|
14.0
|
0.82
|
0.75–0.90
|
< 0.001
|
0.82
|
0.75–0.90
|
< 0.001
|
|
70–79 years
|
11.4
|
0.65
|
0.58–0.73
|
< 0.001
|
0.67
|
0.59–0.76
|
< 0.001
|
|
≥ 80 years
|
8.5
|
0.46
|
0.39–0.56
|
< 0.001
|
0.51
|
0.41–0.62
|
< 0.001
|
|
Sex
|
|
Female
|
13.7
|
Ref.
| | |
Ref.
| | |
|
Male
|
14.4
|
1.06
|
0.98–1.15
|
0.152
|
1.03
|
0.95–1.12
|
0.495
|
|
Marital status
|
|
Cohabiting
|
14.3
|
Ref.
| | |
Ref.
| | |
|
Single
|
13.5
|
0.93
|
0.86–1.01
|
0.103
|
1.08
|
0.99–1.18
|
0.086
|
|
Education
|
|
No university degree
|
12.9
|
Ref.
| | |
Ref.
| | |
|
University degree
|
16.4
|
1.33
|
1.22–1.44
|
< 0.001
|
1.29
|
1.18–1.41
|
< 0.001
|
|
Smoking status
|
|
Not current smoker
|
14.0
|
Ref.
| | |
Ref.
| | |
|
Current smoker
|
13.9
|
1.00
|
0.90–1.12
|
0.990
|
0.91
|
0.81–1.02
|
0.111
|
|
Experience of cancer (self and/or family/friend)
|
|
Yes
|
14.2
|
Ref.
| | |
Ref.
| | |
|
No
|
12.6
|
0.87
|
0.78–0.97
|
0.010
|
0.85
|
0.76–0.95
|
0.006
|
|
Country
|
|
UK
|
13.6
|
Ref.
| | |
Ref.
| | |
|
Australia
|
8.6
|
0.59
|
0.52–0.68
|
< 0.001
|
0.60
|
0.52–0.68
|
< 0.001
|
|
Canada
|
15.1
|
1.13
|
1.01–1.27
|
0.033
|
1.04
|
0.93–1.17
|
0.480
|
|
Denmark
|
14.6
|
1.08
|
0.94–1.25
|
0.270
|
1.00
|
0.86–1.16
|
0.990
|
|
Norway
|
19.4
|
1.52
|
1.34–1.74
|
< 0.001
|
1.46
|
1.27–1.68
|
< 0.001
|
|
Sweden
|
17.1
|
1.31
|
1.14–1.50
|
< 0.001
|
1.22
|
1.06–1.41
|
0.005
|
|
Test of moderation
|
|
Negative beliefs x Non-recognition of unexplained bleeding
| | | | |
0.84
|
0.75–0.95
|
0.005
|
|
Likelihood-ratio test
|
|
LR chi2
| | | | | | |
7.97
|
|
P-value
| | | | | | |
0.005
|
- *All independent variables were included in the same model
